139 related articles for article (PubMed ID: 36798226)
1. MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state.
You SF; Brase L; Filipello F; Iyer AK; Del-Aguila J; He J; D'Oliveira Albanus R; Budde J; Norton J; Gentsch J; Dräger NM; Sattler SM; Kampmann M; Piccio L; Morris JC; Perrin RJ; McDade E; ; Paul SM; Cashikar AG; Benitez BA; Harari O; Karch CM
medRxiv; 2023 Feb; ():. PubMed ID: 36798226
[TBL] [Abstract][Full Text] [Related]
2. The
Deming Y; Filipello F; Cignarella F; Cantoni C; Hsu S; Mikesell R; Li Z; Del-Aguila JL; Dube U; Farias FG; Bradley J; Budde J; Ibanez L; Fernandez MV; Blennow K; Zetterberg H; Heslegrave A; Johansson PM; Svensson J; Nellgård B; Lleo A; Alcolea D; Clarimon J; Rami L; Molinuevo JL; Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Ewers M; Harari O; Haass C; Brett TJ; Benitez BA; Karch CM; Piccio L; Cruchaga C
Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413141
[TBL] [Abstract][Full Text] [Related]
3. Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.
Winfree RL; Nolan E; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Seto M; Petyuk VA; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ;
Mol Neurodegener; 2024 May; 19(1):41. PubMed ID: 38760857
[TBL] [Abstract][Full Text] [Related]
4. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
Wang L; Nykänen NP; Western D; Gorijala P; Timsina J; Li F; Wang Z; Ali M; Yang C; Liu M; Brock W; Marquié M; Boada M; Alvarez I; Aguilar M; Pastor P; Ruiz A; Puerta R; Orellana A; Rutledge J; Oh H; Greicius MD; Le Guen Y; Perrin RJ; Wyss-Coray T; Jefferson A; Hohman TJ; Graff-Radford N; Mori H; Goate A; Levin J; Sung YJ; Cruchaga C
Mol Neurodegener; 2024 Jan; 19(1):1. PubMed ID: 38172904
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
6. Shifting paradigms: The central role of microglia in Alzheimer's disease.
Schwabe T; Srinivasan K; Rhinn H
Neurobiol Dis; 2020 Sep; 143():104962. PubMed ID: 32535152
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.
Brase L; You SF; D'Oliveira Albanus R; Del-Aguila JL; Dai Y; Novotny BC; Soriano-Tarraga C; Dykstra T; Fernandez MV; Budde JP; Bergmann K; Morris JC; Bateman RJ; Perrin RJ; McDade E; Xiong C; Goate AM; Farlow M; ; Sutherland GT; Kipnis J; Karch CM; Benitez BA; Harari O
Nat Commun; 2023 Apr; 14(1):2314. PubMed ID: 37085492
[TBL] [Abstract][Full Text] [Related]
8. African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants.
Schindler SE; Cruchaga C; Joseph A; McCue L; Farias FHG; Wilkins CH; Deming Y; Henson RL; Mikesell RJ; Piccio L; Llibre-Guerra JJ; Moulder KL; Fagan AM; Ances BM; Benzinger TLS; Xiong C; Holtzman DM; Morris JC
Neurol Genet; 2021 Apr; 7(2):e571. PubMed ID: 33884297
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
Tansey KE; Cameron D; Hill MJ
Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
[TBL] [Abstract][Full Text] [Related]
10. Functional insight into LOAD-associated microglial response genes.
Jonas LA; Jain T; Li YM
Open Biol; 2022 Jan; 12(1):210280. PubMed ID: 35078351
[TBL] [Abstract][Full Text] [Related]
11. Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease.
Villegas-Llerena C; Phillips A; Garcia-Reitboeck P; Hardy J; Pocock JM
Curr Opin Neurobiol; 2016 Feb; 36():74-81. PubMed ID: 26517285
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer's Disease.
Liu C; Yu J
Front Aging Neurosci; 2019; 11():297. PubMed ID: 31708768
[TBL] [Abstract][Full Text] [Related]
13. Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
Qin C; Chen M; Dong MH; Yang S; Zhang H; You YF; Zhou LQ; Chu YH; Tang Y; Pang XW; Wu LJ; Tian DS; Wang W
Brain; 2024 Jan; 147(1):163-176. PubMed ID: 37740498
[TBL] [Abstract][Full Text] [Related]
14. Novel late-onset Alzheimer disease loci variants associate with brain gene expression.
Allen M; Zou F; Chai HS; Younkin CS; Crook J; Pankratz VS; Carrasquillo MM; Rowley CN; Nair AA; Middha S; Maharjan S; Nguyen T; Ma L; Malphrus KG; Palusak R; Lincoln S; Bisceglio G; Georgescu C; Schultz D; Rakhshan F; Kolbert CP; Jen J; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Petersen RC; Graff-Radford NR; Dickson DW; Younkin SG; Ertekin-Taner N; ; Apostolova LG; Arnold SE; Baldwin CT; Barber R; Barmada MM; Beach T; Beecham GW; Beekly D; Bennett DA; Bigio EH; Bird TD; Blacker D; Boeve BF; Bowen JD; Boxer A; Burke JR; Buros J; Buxbaum JD; Cairns NJ; Cantwell LB; Cao C; Carlson CS; Carney RM; Carroll SL; Chui HC; Clark DG; Corneveaux J; Cotman CW; Crane PK; Cruchaga C; Cummings JL; De Jager PL; DeCarli C; DeKosky ST; Demirci FY; Diaz-Arrastia R; Dick M; Dombroski BA; Duara R; Ellis WD; Evans D; Faber KM; Fallon KB; Farlow MR; Ferris S; Foroud TM; Frosch M; Galasko DR; Gallins PJ; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Gilman S; Giordani B; Glass JD; Goate AM; Green RC; Growdon JH; Hakonarson H; Hamilton RL; Hardy J; Harrell LE; Head E; Honig LS; Huentelman MJ; Hulette CM; Hyman BT; Jarvik GP; Jicha GA; Jin LW; Jun G; Kamboh MI; Karlawish J; Karydas A; Kauwe JS; Kaye JA; Kennedy N; Kim R; Koo EH; Kowall NW; Kramer P; Kukull WA; Lah JJ; Larson EB; Levey AI; Lieberman AP; Lopez OL; Lunetta KL; Mack WJ; Marson DC; Martin ER; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Montine TJ; Morris JC; Myers AJ; Naj AC; Nowotny P; Parisi JE; Perl DP; Peskind E; Poon WW; Potter H; Quinn JF; Raj A; Rajbhandary RA; Raskind M; Reiman EM; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rogaeva E; Rosenberg RN; Sano M; Saykin AJ; Schneider JA; Schneider LS; Seeley W; Shelanski ML; Slifer MA; Smith CD; Sonnen JA; Spina S; St George-Hyslop P; Stern RA; Tanzi RE; Trojanowski JQ; Troncoso JC; Tsuang DW; Van Deerlin VM; Vardarajan BN; Vinters HV; Vonsattel JP; Wang LS; Weintraub S; Welsh-Bohmer KA; Williamson J; Woltjer RL
Neurology; 2012 Jul; 79(3):221-8. PubMed ID: 22722634
[TBL] [Abstract][Full Text] [Related]
15. CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.
Ma Y; Jun GR; Chung J; Zhang X; Kunkle BW; Naj AC; White CC; Bennett DA; De Jager PL; ; Mayeux R; Haines JL; Pericak-Vance MA; Schellenberg GD; Farrer LA; Lunetta KL
Aging Cell; 2019 Aug; 18(4):e12964. PubMed ID: 31144443
[TBL] [Abstract][Full Text] [Related]
16. Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics.
Podleśny-Drabiniok A; Marcora E; Goate AM
Trends Neurosci; 2020 Dec; 43(12):965-979. PubMed ID: 33127097
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of Alzheimer's disease genetic variants in microglia.
Yang X; Wen J; Yang H; Jones IR; Zhu X; Liu W; Li B; Clelland CD; Luo W; Wong MY; Ren X; Cui X; Song M; Liu H; Chen C; Eng N; Ravichandran M; Sun Y; Lee D; Van Buren E; Jiang MZ; Chan CSY; Ye CJ; Perera RM; Gan L; Li Y; Shen Y
Nat Genet; 2023 Oct; 55(10):1735-1744. PubMed ID: 37735198
[TBL] [Abstract][Full Text] [Related]
18. MS4A Cluster in Alzheimer's Disease.
Ma J; Yu JT; Tan L
Mol Neurobiol; 2015; 51(3):1240-8. PubMed ID: 24981432
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease.
Tsai AP; Dong C; Lin PB; Oblak AL; Viana Di Prisco G; Wang N; Hajicek N; Carr AJ; Lendy EK; Hahn O; Atkins M; Foltz AG; Patel J; Xu G; Moutinho M; Sondek J; Zhang Q; Mesecar AD; Liu Y; Atwood BK; Wyss-Coray T; Nho K; Bissel SJ; Lamb BT; Landreth GE
Immunity; 2023 Sep; 56(9):2121-2136.e6. PubMed ID: 37659412
[TBL] [Abstract][Full Text] [Related]
20. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
Suárez-Calvet M; Kleinberger G; Araque Caballero MÁ; Brendel M; Rominger A; Alcolea D; Fortea J; Lleó A; Blesa R; Gispert JD; Sánchez-Valle R; Antonell A; Rami L; Molinuevo JL; Brosseron F; Traschütz A; Heneka MT; Struyfs H; Engelborghs S; Sleegers K; Van Broeckhoven C; Zetterberg H; Nellgård B; Blennow K; Crispin A; Ewers M; Haass C
EMBO Mol Med; 2016 May; 8(5):466-76. PubMed ID: 26941262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
